Partner with Seclis Labs for reliable Third Party Manufacturing at WHO-GMP certified facilities. Custom formulations, competitive pricing, DCGI-approved products, and on-time delivery — everything you need to build your pharma brand without investing in a manufacturing plant.
Third Party Manufacturing — also known as contract manufacturing or loan licence manufacturing — is a business arrangement in which a pharmaceutical brand owner outsources the production of its medicines to a licensed manufacturing facility. The brand owner retains full rights over the product name, formulation, and marketing, while the manufacturing partner handles production, quality control, and packaging.
In India, Third Party Manufacturing is one of the fastest-growing models in the pharmaceutical sector. According to Invest India, India is the world's third-largest pharmaceutical producer by volume and supplies over 50% of global vaccine demand — a position built significantly on the strength of its contract manufacturing ecosystem.
The Third Party Manufacturing model allows pharmaceutical entrepreneurs, marketing companies, and PCD franchise businesses to launch their own branded products without the enormous capital investment required to build and license their own manufacturing plant. Instead of spending crores on machinery, staff, and regulatory approvals, you partner with an established manufacturer like Seclis and get market-ready products delivered to your warehouse.
Seclis Labs operates its Third Party Manufacturing programme from WHO-GMP certified facilities fully compliant with CDSCO's Schedule M Good Manufacturing Practices. Every product we manufacture carries a valid DCGI approval and is accompanied by a Certificate of Analysis (COA) and quality test reports — giving you complete confidence in what you're putting your brand name on.
Choosing the right Third Party Manufacturing partner is critical — the quality of your products directly determines your brand's reputation. Here's what makes Seclis the trusted choice.
Our Third Party Manufacturing facilities are certified under WHO Good Manufacturing Practices — the internationally recognised quality standard. Every batch is manufactured under strict environmental and process controls.
We manufacture products under your brand name with your custom packaging design. Our formulation team assists with product development, composition refinement, and DCGI approval documentation for new formulations.
Every batch produced in our Third Party Manufacturing facility is tested in our in-house quality control laboratory before dispatch. You receive a Certificate of Analysis (COA), batch test reports, and complete manufacturing documentation with every order.
Timely delivery is non-negotiable in Third Party Manufacturing. Seclis operates a robust pan-India logistics network ensuring first orders are dispatched within 45–60 days and repeat orders within 15–21 days.
Seclis offers Third Party Manufacturing across a comprehensive range of dosage forms — from solid oral formulations to complex injectables. Whether you need a single product or a full portfolio, our manufacturing capabilities cover your requirements.
All dosage forms are manufactured in dedicated production suites with environmental monitoring, validated equipment, and trained operators — in full compliance with CDSCO Schedule M and WHO-GMP requirements.
Request Product Catalogue →From your first enquiry to the moment your branded products are delivered — here is exactly how our Third Party Manufacturing process works at Seclis.
Share your product requirements — molecules, compositions, dosage forms, and quantities. Our team provides pricing, MOQ details, and confirms regulatory status for each product.
Submit your Wholesale Drug Licence and GST certificate. We execute a formal Third Party Manufacturing agreement defining product specifications, pricing, delivery timelines, and quality standards.
Design your product packaging as per CDSCO labelling guidelines — composition, batch number, manufacturing date, expiry, and required statutory declarations. We guide you through compliance.
We source Active Pharmaceutical Ingredients (APIs) and excipients exclusively from GMP-certified, CDSCO-approved vendors. Raw material quality is verified before production begins.
Production takes place in our WHO-GMP certified facility under continuous in-process quality monitoring. Batch manufacturing records are maintained for every production run.
Finished goods undergo final quality testing in our in-house laboratory. Approved batches are packed, labelled, and dispatched with COA, test reports, and all required documents.
Third Party Manufacturing is the most capital-efficient way to launch and scale a pharmaceutical brand in India. According to the India Brand Equity Foundation, India's pharma sector is expected to reach USD 130 billion by 2030 — and Third Party Manufacturing is central to how brands will scale to capture that growth.
The Government of India's Production Linked Incentive (PLI) Scheme for Pharmaceuticals has committed over ₹15,000 crore to strengthen India's manufacturing base — making this an ideal time to partner with an established Third Party Manufacturing company like Seclis.
All products manufactured under our Third Party Manufacturing programme comply with:
Our Third Party Manufacturing capabilities span 20+ therapeutic categories — giving you the flexibility to build a focused niche portfolio or a broad multi-segment catalogue.
Talk to our team today. Get pricing, product availability, and a complete manufacturing proposal within 24 hours.